Press-release for stocks publishing date 2022 - 05

Prices are updated after-hours

publishing date : 2022 - 05 - 03

save search

Aclaris Therapeutics to Participate in the LifeSci Partners Immunology & Inflammation Symposium
Published: 2022-05-03 (Crawled : 15:20) - globenewswire.com
ACRS A | $16.41 -1.09% -1.1% 470K

Health Technology

| 33.05% | O: -0.39% H: 3.1% C: 1.32%
immunology symposium therapeutics

Pete Buttigieg, der Minister des US-Verkehrsministeriums, besichtigt den Einsatz der intelligenten Infrastrukturlösung von Velodyne Lidar an der Morgan State
Published: 2022-05-03 (Crawled : 18:00) - velodynelidar.com
VLDR | $1.5 5.63% 5.33% 5.9M

Electronic Technology

| -26.6% | O: 6.91% H: 1.49% C: 1.0%
state lidar

Pete Buttigieg, Segretario del Dipartimento dei trasporti degli Stati Uniti, visita un sito di implementazione della soluzione per infrastrutture intelligenti di Velodyne Lidar presso la Morgan State University
Published: 2022-05-03 (Crawled : 17:00) - velodynelidar.com
VLDR | $1.5 5.63% 5.33% 5.9M

Electronic Technology

| -26.6% | O: 6.91% H: 1.49% C: 1.0%
state lidar

Atea Pharmaceuticals to Host First Quarter 2022 Financial Results Conference Call on May 10, 2022
Published: 2022-05-03 (Crawled : 20:20) - ir.ateapharma.com
AVIR A | $4.52 -4.64% -4.87% 880K

Health Technology

| -23.18% | O: 0.0% H: 0.0% C: -0.81%
conference results

Ocular Therapeutix™ To Present Pre-Clinical Data at the American Society of Gene & Cell Therapy (ASGCT) 25th Annual Meeting
Published: 2022-05-03 (Crawled : 16:20) - ocutx.gcs-web.com
OCUL A | $4.325 2.01% 1.97% 670K

Health Technology

| 4.43% | O: 0.25% H: 0.98% C: 0.98%
pre-clinical ocular therapy preclinical

Jaguar Health Completes Final Regulatory Filing for Conditional New Animal Drug Approval of Canalevia (Crofelemer) to Treat Exercise-induced Diarrhea (EID) in Dogs
Published: 2022-05-03 (Crawled : 16:20) - jaguarhealth.gcs-web.com
JAGX | $4.71 4.2% 4.03% 970K

Health Technology

| 904.0% | O: 2.18% H: 2.17% C: -0.41%
drug diarrhea for health approval

Heat Biologics Completes Name Change to NightHawk Biosciences; Trading to Commence Under “NHWK” Effective at the Market Open Today
Published: 2022-05-03 (Crawled : 01:00) - biospace.com/
HTBX 4 | $2.38 0%

Health Technology

| Email alert Add to watchlist
today market

Kala Pharmaceuticals Announces New Commercial and Medicare Coverage for EYSUVIS®
Published: 2022-05-03 (Crawled : 01:00) - biospace.com/
KALA | $17.57 -2.66% -2.73% 110K

Health Technology

| 2275.0% | O: 5.82% H: 0.0% C: 0.0%
eysuvis for

SeaStar Medical Granted FDA Breakthrough Device Designation for a Novel Immunomodulatory Therapy for Acute Kidney Injury Patients
Published: 2022-05-03 (Crawled : 01:00) - biospace.com/
LMAO | $12.35 3.89%

| 21.67% | O: 0.1% H: 0.0% C: 0.0%
fda designation device for kidney granted therapy

Achilles Therapeutics to Present at Upcoming Conferences
Published: 2022-05-03 (Crawled : 01:00) - biospace.com/
ACHL | $1.21 0.0% 140K

Manufacturing

| -45.25% | O: 5.43% H: 0.0% C: 0.0%
therapeutics

Equinox Gold Reports First Quarter 2022 Financial and Operating Results
Published: 2022-05-03 (Crawled : 01:00) - prnewswire.com
EQX | $4.61 1.77% 0.0% 1.1M

Non-Energy Minerals

| -35.23% | O: -7.74% H: 0.0% C: 0.0%
results

Codex DNA to Report First Quarter 2022 Financial Results on Tuesday, May 10, 2022
Published: 2022-05-03 (Crawled : 00:00) - biospace.com/
DNAY | $1.3 8.33% -1.54%

Professional, Scientific, and T...

| -70.32% | O: 1.2% H: 0.0% C: 0.0%
report results

Erasca to Present at the Bank of America Securities 2022 Healthcare Conference
Published: 2022-05-03 (Crawled : 00:00) - biospace.com/
ERAS A | $4.35 4.82% 4.6% 1.9M

| -47.53% | O: 2.02% H: 0.0% C: 0.0%
america conference

Eton Pharmaceuticals to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022
Published: 2022-05-03 (Crawled : 00:00) - biospace.com/
ETON | $3.495 0.72% 0.72% 59K

Health Technology

| -2.8% | O: 2.52% H: 0.0% C: 0.0%
report results

CERNER REPORTS FIRST QUARTER 2022 RESULTS
Published: 2022-05-03 (Crawled : 00:00) - biospace.com/
CERN | $94.92 0.03%

Technology Services

| 1.17% | O: -0.09% H: 0.0% C: 0.0%
results

MacroGenics Provides Update on Corporate Progress and First Quarter 2022 Financial Results
Published: 2022-05-03 (Crawled : 00:00) - biospace.com/
PRVB | $9.28 1.98% 1.94% 1.1M

Health Technology

| 89.08% | O: 1.26% H: 0.0% C: 0.0%
MGNX | $5.595 -5.49% -5.81% 570K

Health Technology

| -22.0% | O: -0.66% H: 0.0% C: 0.0%
results

NextCure to Present at the BofA Securities 2022 Healthcare Conference
Published: 2022-05-03 (Crawled : 00:00) - biospace.com/
NXTC | $1.67 -0.6% -0.6% 92K

Health Technology

| -58.92% | O: 0.24% H: 0.0% C: 0.0%
conference